Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Lau

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral AgentsCheng Wang, Dong Ji, Jing Chen, et al.
Antiviral Research|December 18, 2025
Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis BDong Ji, Meng-Wen He, Wen-Chang Wang, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Frontiers in Cellular and Infection Microbiology|August 22, 2024
Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatmentZhong-Bin Li, Dan-Dan Chen, Yun-Fei Jia, et al.
Gastroenterology|January 28, 2014
Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNAHenry L Y Chan, Chi Kuen Chan, Aric Josun Hui, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistanceScott Preiss, Margaret Littlejohn, Peter Angus, et al.
Hepatology International|May 4, 2021
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitisGuiqiang Wang, Atsushi Tanaka, Hong Zhao, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspectivePeter Ferenci, Michael Fried, Douglas Labrecque, et al.
Hepatology International|June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysisJing Chen, Dong Ji, Jidong Jia, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral AgentsCheng Wang, Dong Ji, Jing Chen, et al.
Antiviral Research|December 18, 2025
Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis BDong Ji, Meng-Wen He, Wen-Chang Wang, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Frontiers in Cellular and Infection Microbiology|August 22, 2024
Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatmentZhong-Bin Li, Dan-Dan Chen, Yun-Fei Jia, et al.
Gastroenterology|January 28, 2014
Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNAHenry L Y Chan, Chi Kuen Chan, Aric Josun Hui, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistanceScott Preiss, Margaret Littlejohn, Peter Angus, et al.
Hepatology International|May 4, 2021
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitisGuiqiang Wang, Atsushi Tanaka, Hong Zhao, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspectivePeter Ferenci, Michael Fried, Douglas Labrecque, et al.
Hepatology International|June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysisJing Chen, Dong Ji, Jidong Jia, et al.
Pageof 10